Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by Whatshisfaceon Apr 09, 2018 4:44pm
166 Views
Post# 27855492

APHRIA MAY SOON BE ABLE TO SELL CANNABIS PROD. IN ARGENTINA

APHRIA MAY SOON BE ABLE TO SELL CANNABIS PROD. IN ARGENTINAScythian Biosciences is in the process of aquiring APB SA in Argentina. If they are able to get the deal done this will open up Argentina as a sales market for Aphria. The population is 42 million, so the market is bigger than Canada. And Aphria is already making 8 mil plus / quarter in Canada. Did they just double their revenues? We will see...
Under the terms of the Supply Agreement, Aphria will supply ABP with cannabis pr
oducts for
research and development purposes as well as for distribution to hospitals, retail
pharmacies,
and private health providers in Argentina’s public health system.

 

Bullboard Posts